Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Early Use Of Novocure's Brain Cancer Therapy Shows no Significant Survival Benefit in Late-stage Trial

Novocure said on Thursday that a late-stage trial showed early use of its non-invasive cancer therapy ⁠did not significantly improve overall survival in patients with newly...

GLP-1s Could Help Improve Symptoms of PMOS

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Medicine Shortages Among Worst Ever Seen, Pharmacists Warn

Health leaders are calling for an emergency taskforce as record-breaking shortages hit patients and stretch pharmacies to the limit.

Tirzepatide Tops Semaglutide in Real-World Weight Loss

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

Are GLP-1s Increasing Eating Disorder Risk?

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

US FDA Sends 25 Letters to Telehealth Companies Over Claims on Compounded Weight-loss Drugs

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Todays Updates

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Simple well-timed prompts to clinicians and patients with advanced cancer can increase conversations around care goals, but clear documentation remains a challenge.

Latest News

Novocure said on Thursday that a late-stage trial showed early use of its non-invasive cancer therapy ⁠did not significantly improve overall survival in patients with newly...

The metabolic symptoms of PMOS, including overweight and diabetes, may be effectively treated by GLP-1s.

Health leaders are calling for an emergency taskforce as record-breaking shortages hit patients and stretch pharmacies to the limit.

Tirzepatide leads to greater and faster weight loss than semaglutide in a real-world analysis of more than 20,000 patients with obesity.

With GLP-1s readily available, some experts fear misuse is increasing and may be fueling eating disorders. Physicians describe what they are seeing and how they manage the risks.

The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about ⁠compounded versions of Eli Lilly and...

News All Time

GLP-1s Aren’t a Solo Act. They Need Comprehensive Planning

Lifestyle changes, tracking, and support should go hand-in-hand with weight loss drugs.

AI Eye Scan Cuts Unneeded Diabetes Macular Edema Referrals

An AI-based OCT system integrated into standard diabetic retinopathy screening pathways reduces unwarranted referrals for diabetic macular edema, a recent study shows.

Neumora Scraps Depression Drug Development After Repeated Trial Failures

Neumora Therapeutics will abandon the development of its experimental depression drug following the latest trial failures and ⁠said it would cut 35% of its workforce,...

Chronic Opioid Use Raises Risk for Endocrinopathies

Possible complications include adrenal insufficiency, hypogonadism, hyperprolactinemia, hospitalization, and mortality.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Novo Nordisk Flags Patient Data Breach From Some Clinical Trials in Cyberattack

Novo Nordisk said on Thursday it has identified a security incident in which certain information, including ⁠patient data from some clinical trials, was copied externally...

Tirzepatide Outperforms Conventional Care in Early Diabetes

Tirzepatide offered better glycemic control and greater weight loss than intensive conventional care in adults with early type 2 diabetes, a study finds.

AI-Guided Prep Improves Bariatric Surgery Consults

A structured, AI-supported metacognitive framework substantially enhances the quality of metabolic and bariatric surgery consultations.

PMOS: Insulin Resistance Affects Fertility and Pregnancy

Prepregnancy insulin resistance is associated with impaired fertility and increased pregnancy complications such as preeclampsia.

Over-the-Counter CGM Okayed for Kids

The US FDA extended the age of use for Dexcom’s Stelo down to 2 years.

Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits

The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options for targeted treatment.

Older Drug Reprograms White Blood Cells, Improves Blood Sugar in Type 1 Diabetes

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Recommended News For You

a cutting-edge cancer diagnostic tool.

Products for Intimate Care and Cancer; Boost for Colorectal Cancer Stool Tests; Ultrasonic Biopsy?

According to new studies, some cancer patients can safely forego radiation therapy.

Rural-urban disparities seen in cervical cancer

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

High levels of traumatic stress found in caregivers of adult cancer patients

Recommended Articles For You

RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health  

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment 

The Science Behind Thrombolytic Drugs and Their Benefits  

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

2.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

3.

Shorter, less intense regimen still effective for HPV-linked throat cancer, study shows

4.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

5.

Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

1.

Unlocking the Potential of Plinabulin: A New Frontier in Cancer Treatment

2.

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy

3.

Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring

4.

Emerging Models in Oncology for Specialists

5.

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

2.

Navigating the Complexities of Ph Negative ALL - Part XI

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot